"the funding that’s the problem"
no its not
Its despite having "two world class FDA /CE approved products " and they still need funding is the problem.
They cant even keep their shares trading on the market.
Ann: Extension for Voluntary Suspension, page-220
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.10 |
Change
-0.550(3.51%) |
Mkt cap ! $288.9M | |||
| Open | High | Low | Value | Volume |
| $15.75 | $15.75 | $15.00 | $195.1K | 12.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 376 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.17 | 68 | 4 |
View Market Depth
| Last trade - 15.27pm 29/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |